Stephen J. Balevic

864 total citations
54 papers, 487 citations indexed

About

Stephen J. Balevic is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Rheumatology. According to data from OpenAlex, Stephen J. Balevic has authored 54 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pediatrics, Perinatology and Child Health, 16 papers in Public Health, Environmental and Occupational Health and 12 papers in Rheumatology. Recurrent topics in Stephen J. Balevic's work include Systemic Lupus Erythematosus Research (11 papers), Pharmaceutical studies and practices (10 papers) and Pregnancy and Medication Impact (10 papers). Stephen J. Balevic is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Pharmaceutical studies and practices (10 papers) and Pregnancy and Medication Impact (10 papers). Stephen J. Balevic collaborates with scholars based in United States, Canada and Germany. Stephen J. Balevic's co-authors include Michael Cohen‐Wolkowiez, Megan E. B. Clowse, Amanda M. Eudy, Laura E. Schanberg, Christoph P. Hornik, Daniel González, C. Egla Rabinovich, Thomas P. Green, Anil R. Maharaj and Andrea N. Edginton and has published in prestigious journals such as Nature Communications, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Stephen J. Balevic

51 papers receiving 473 citations

Peers

Countries citing papers authored by Stephen J. Balevic

Since Specialization

Citations

This map shows the geographic impact of Stephen J. Balevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Balevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Balevic more than expected).

Fields of papers citing papers by Stephen J. Balevic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Balevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Balevic. The network helps show where Stephen J. Balevic may publish in the future.

Co-authorship network of co-authors of Stephen J. Balevic

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Balevic. A scholar is included among the top collaborators of Stephen J. Balevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Balevic. Stephen J. Balevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial 2025 ·Nature Communications ·Jeffrey Clarke, George R. Simon, Hirva Mamdani, Lin Gu, James E. Herndon, Thomas E. Stinchcombe, Neal Ready, Jeffrey Crawford, Guru Sonpavde, Stephen J. Balevic, Andrew B. Nixon, Michael J. Campa, Elizabeth B. Gottlin, Huihua Li, Ruchi Saxena, You‐Wen He, Scott Antonia, Edward F. Patz	7
2	Population Pharmacokinetics of Alfentanil in Children 2025 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), Chi D. Hornik, Amira Al‐Uzri, Rachel G. Greenberg, (unknown), Elizabeth H. Payne, (unknown), Stephen J. Balevic	0
3	Physiologically Based and Population Pharmacokinetic Modeling of Midazolam in Children With Obesity Using Real‐World Data 2025 ·Clinical and Translational Science ·(unknown), (unknown), Stephen J. Balevic, William J. Muller, John van den Anker, Amira Al‐Uzri, (unknown), (unknown), (unknown), Andrea N. Edginton, Daniel González	1
4	Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis 2024 ·Arthritis Care & Research ·Melissa L. Mannion, (unknown), Stephen J. Balevic, Min‐Lee Chang, C. Correll, Lianne Kearsley‐Fleet, Kimme L Hyrich, Timothy Beukelman	2
5	Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population 2024 ·CPT Pharmacometrics & Systems Pharmacology ·Elizabeth J. Thompson, Angela Jeong, (unknown), Valentina Shakhnovich, Andrea N. Edginton, Stephen J. Balevic, Laura P. James, David N. Collier, Ravinder Anand, Daniel González	4
6	Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants 2024 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Stephen J. Balevic, Chi D. Hornik, Stuart L. Goldstein, Julie Autmizguine, (unknown), Amira Al‐Uzri, (unknown), Elizabeth H. Payne, (unknown), Daniel González	2
7	Azathioprine metabolite levels and outcomes during pregnancies with rheumatic disease 2024 ·Lupus Science & Medicine ·Stephen J. Balevic, (unknown), Amanda M. Eudy, Valerie A. Smith, Megan E. B. Clowse	2
8	Pharmacokinetics of Oral Vitamin D in Children with Obesity and Asthma 2023 ·Clinical Pharmacokinetics ·Jason E. Lang, (unknown), Stephen J. Balevic, Scott Bickel, Christoph P. Hornik, Joseph M. Majure, (unknown), Jessica Snowden, Brian O’Sullivan, Laura P. James	2
9	Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry 2023 ·RMD Open ·C. Correll, Scott Stryker, David H. Collier, Thomas Phillips, Anne Dennos, Stephen J. Balevic, Timothy Beukelman	1
10	Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data 2022 ·Lupus Science & Medicine ·Megan E. B. Clowse, Amanda M. Eudy, Stephen J. Balevic, (unknown), Andrzej S. Kosinski, Rebecca Fischer‐Betz, Dafna D. Gladman, Yair Molad, Cecilia Nalli, Abir Mokbel, Anǵela Tincani, Murray B. Urowitz, (unknown), Megan Van Noord, Michelle Petri	39
11	External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data 2022 ·Frontiers in Pharmacology ·Eleni Karatza, Samit Ganguly, Chi D. Hornik, William J. Muller, Amira Al‐Uzri, Laura P. James, Stephen J. Balevic, Daniel González	4
12	Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions 2022 ·Infectious Diseases and Therapy ·Stephen J. Balevic, Shruti M. Raja, (unknown), Gregory A. Deye, Thomas Conrad, Aya Nakamura, David H. Peyton, (unknown), (unknown), Michael Cohen‐Wolkowiez, Jeffrey T. Guptill	4
13	Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease 2022 ·Early Human Development ·Jessica E. Ericson, Daniel K. Benjamin, Felix Boakye‐Agyeman, Stephen J. Balevic, C. Michael Cotten, Felice C. Adler‐Shohet, Matthew M. Laughon, Brenda B. Poindexter, (unknown), Elizabeth H. Payne, (unknown), P. Brian Smith	2
14	Precision Medicine 2021 ·Rheumatic Disease Clinics of North America ·Stephen J. Balevic, (unknown)	2
15	Comparative efficacy and safety of late surfactant preparations: a retrospective study 2021 ·Journal of Perinatology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stephen J. Balevic, Wesley Jackson, Matthew M. Laughon, Christoph P. Hornik, Rachel G. Greenberg, Reese H. Clark, Kanecia O. Zimmerman	3
16	Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials 2020 ·The Journal of Rheumatology ·Stephen J. Balevic, Christoph P. Hornik, Thomas P. Green, Megan E. B. Clowse, Daniel González, Anil R. Maharaj, Laura E. Schanberg, Amanda M. Eudy, Geeta K. Swamy, Brenna L. Hughes, Michael Cohen‐Wolkowiez	16
17	Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019 2020 ·JAMA Pediatrics ·Anil R. Maharaj, Huali Wu, Christoph P. Hornik, Stephen J. Balevic, Chi D. Hornik, P. Brian Smith, Daniel González, Kanecia O. Zimmerman, Daniel K. Benjamin, Michael Cohen‐Wolkowiez	30
18	Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants 2018 ·Early Human Development ·(unknown), P. Brian Smith, Matthew M. Laughon, Ronald N. Goldberg, Lawrence Ku, Kanecia O. Zimmerman, Stephen J. Balevic, Reese H. Clark, Daniel K. Benjamin, Rachel G. Greenberg	16
19	Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes 2018 ·The Journal of Rheumatology ·Stephen J. Balevic, Michael Cohen‐Wolkowiez, Amanda M. Eudy, Thomas P. Green, Laura E. Schanberg, Megan E. B. Clowse	28
20	Clinical Trial Design in Juvenile Idiopathic Arthritis 2017 ·Pediatric Drugs ·Stephen J. Balevic, Mara L. Becker, Michael Cohen‐Wolkowiez, Laura E. Schanberg	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact